KLRS vs TT
Kalaris Therapeutics, Inc. (KLRS) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Kalaris Therapeutics, Inc. (KLRS) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
KLRS does not have a complete income-statement cache yet.
Latest reported TT revenue for 2026-06-30 was $11.32B. Net income was $1.51B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
KLRS currently screens at market cap $0. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the KLRS and TT stock pages for the full models.
Not investment advice.